Will COVID Vaccines Increase Risk of AIDS Virus?

VaxInsider – October 29, 2020 treihm 10 Comments

New cause for concern underlines the importance of full transparency on COVID vaccine data, which we are not getting. Action Alert!

We at ANH-USA, along with our friends at ANH-International, have been calling for full transparency on the development of COVID-19 vaccines. It’s becoming clear that this will only be achieved if the public fights for it, as vaccine manufacturers have not done so willingly. With experts warning of the potential of COVID vaccines to make us more susceptible to the AIDS virus, transparency is more important than ever. We must continue to demand full transparency so the public can make an informed decision about risks and benefits to any approved vaccine.

The public, having committed billions of dollars to vaccine manufacturers, deserves to see everything that is going on. Only then can informed decisions be made about the safety of any approved COVID-19 vaccine. Experts are already sounding the alarm, with some warning that COVID-19 vaccines could leave patients more susceptible to the HIV virus, which of course can lead to AIDS; this is what happened in a previous HIV vaccine candidate when a certain adenovirus was used to deliver proteins of the HIV virus, and the same adenovirus is now being used in some COVID-19 vaccines in development. Given that vaccines approved under “normal” circumstances can still be dangerous, we need to be vigilant with a vaccine that will be approved on a drastically shortened timetable. If you have any doubts about the dangers of fast-tracked vaccines, please take a look at our coverage of the HPV vaccine.

Note too that the flu shot may increase our vulnerability to COVID-19. A Department of Defense study in 2018 found that individuals vaccinated against the flu were 36 percent more likely to test positive for a coronavirus than unvaccinated individuals. There are other studies that also suggest flu vaccination increases the risk of non-flu viral infections and respiratory illness. Keep in mind that this is exactly what COVID is: a non-flu respiratory illness.

To date, we are not getting full transparency. In September, we learned that AstraZeneca’s clinical trial had been halted over safety concerns after a person who was given the vaccine experienced neurological problems. But the only reason we learned this news was the information was leaked from a private investor call. The trial was eventually cleared to begin again, but the company didn’t provide any details about the patient’s medical condition, nor did they release a transcript of the private call with investors. AstraZeneca had received $1 billion from the government’s Operation Warp Speed initiative to fund vaccine research and development.

After this episode, and after months of public calls, including from ANH members, demanding full transparency, Pfizer, Moderna, Janssen, and AstraZeneca finally released their clinical trial protocols. The transparency manifesto from ANH-International we are supporting calls for much more, including full disclosure of raw data from clinical trials, full disclosure of vaccine composition in commercial formulations, conduct of studies to evaluate the safety of adjuvants, and much more.

The refrain in the media is that things can’t go back to normal until there’s a vaccine. The story that’s not being told, and is in fact being aggressively blocked by the federal government, is that natural medicines can help prevent or treat COVID-19. Until we address this unlevel playing field, the healthcare landscape cannot meaningfully change in this country.

Action Alert! Write to Congress and tell them we need full transparency on any COVID vaccine approval.  Please send your message immediately. By sending this message, you will also be supporting our petition to ungag doctors so that they can share with patients the benefits of supplements and natural treatments for COVID.

Take action in your state to protect vaccine choice:

Illinois

Kentucky

Louisiana

Massachusetts

Michigan

New Jersey

New York

Pennsylvania

Vermont

Virginia

Posted in: Uncategorized